Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Tumor size is a potential predictor of response to tyrosine kinase inhibitors in renal cell cancer.

Yuasa T, Urakami S, Yamamoto S, Yonese J, Nakano K, Kodaira M, Takahashi S, Hatake K, Inamura K, Ishikwa Y, Fukui I. Tumor size is a potential predictor of response to tyrosine kinase inhibitors in renal cell cancer. Urology. 2011 Apr; 77(4):831-5.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.